Wednesday, May 17 2023
09:15 AM – 09:40 AM PT
Use of Rat Data to Support an IND for a Rare Disease Trial (NGLY1)
Becky Schweighardt, PhD. Grace Science, LLC, Menlo Park, CA
Disclosures: B. Schweighardt: 1; Commercial Interest i.e. Company X; Grace Science, LLC. 1; What was received? i.e. Honorarium; salary and stock options. 1; For what role? i.e. Speaker; employee and stock holder.